Invention Grant
- Patent Title: Benzodiazepine bromodomain inhibitor
-
Application No.: US14753326Application Date: 2015-06-29
-
Publication No.: US09598420B2Publication Date: 2017-03-21
- Inventor: James Bailey , Romain Luc Marie Gosmini , Olivier Mirguet , Jason Witherington
- Applicant: GlaxoSmithKline LLC
- Applicant Address: US DE Wilmington, New Castle
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US DE Wilmington, New Castle
- Agent Duke M. Fitch; Kathryn A. Lutomski; Edward R. Gimmi
- Priority: GB0919433.3 20091105; GB1010509.6 20100622; WOPCT/EP2010/061518 20100806; GB1014231.3 20100825
- Main IPC: A61K31/551
- IPC: A61K31/551 ; C07D487/04
Abstract:
Benzodiazepine compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.
Public/Granted literature
- US20150299210A1 Benzodiazepine Bromodomain Inhibitor Public/Granted day:2015-10-22
Information query
